Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection

Liqiang Zhang(Peking University Third Hospital), Alexandra Lucas(Arizona State University), Anjali Wilson(Arizona State University), Esther Borges Florsheim(Yale University), Kyle Browder(Arizona State University), Aubrey Pinteric(TOCA at Banner Health), Brenda G. Hogue(Arizona State University), Emily Aliskevich(Arizona State University), Julie Turk(Arizona State University), Masmudur M. Rahman(Arizona State University), Arvind Varsani(Arizona State University), Grant McFadden(Arizona State University), Fernando Arcos Juan(Arizona State University), Nicholas Saldevar(Arizona State University), Aman Garg(Arizona State University), Laurel Spaccarelli(Arizona State University), Junior A. Enow(Arizona State University), Savanah D. Gisriel(Yale University), Efrem S. Lim(Arizona State University), J W Wallen(Healthcentric Advisors), Simona Kraberger(Arizona State University), Nora Elmadbouly(Arizona State University), Bereket Estifanos(Arizona State University), Bertram L. Jacobs(Arizona State University), Vivek Kumar(Fortis Escorts Heart Institute), Karen V. Kibler(Arizona State University), Jessika Schlievert(Arizona State University), Henna Monder(Arizona State University), Rohan Saju(Arizona State University), Timothy L. Karr(Arizona State University), Yize Li(Northeast Agricultural University), Isabela R. Zanetti(Arizona State University)
EMBO Molecular Medicine
August 3, 2023
Cited by 12


Related Papers